Delivery Order HHSF223201310034I-HHSF22301001T

This is a $1,847,030 delivery order contract awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization. The contract is for comparative pharmacokinetics and in vivo genetic toxicology studies of N-Nitrosonornicotine (NNN) in rats. The work is being performed under the FDA's "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract has a firm fixed price...

This is a firm fixed-price delivery order issued by the Department of Health and Human Services Food and Drug Administration under the In Vivo Toxicology of Tobacco 2015-2020 indefinite delivery/indefinite quantity (IDIQ) contract. The $1,408,956.00 task order was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to perform detection and characterization of DNA adducts generated by tobacco flavorants in aerosol...

This firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a for-profit research and testing services company. The contract, valued at $88,156.00, is for a pilot study on the in vivo genetic toxicity of the chemical NNK (nicotine-derived nitrosamine ketone) in mice using the intraperitoneal route of administration. This contract is part of a larger $7.8 million indefinite delivery contract (IDC) awarded by...

This is a $1,127,883.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Battelle Memorial Institute, a nonprofit research organization, to study the human dose-response effects of methyl salicylate in smokeless tobacco products. The contract has a completion date of March 29, 2024 and was awarded on September 24, 2019 without the use of a set-aside. Battelle has subcontracted with three organizations to support...

Technical Resources International, Inc. (TRI) has been awarded a firm fixed price purchase order valued at one million six hundred twenty four thousand one hundred twenty two dollars and twenty cents ($1,624,122.20) by the Department of Health and Human Services' Food and Drug Administration (FDA) to assess nicotine dose discrimination in marketed cigarettes. This purchase order was issued under an indefinite delivery/indefinite quantity contract held by TRI with the National Institutes of...

This firm-fixed-price delivery order was issued under the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The $1,412,105.00 contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute, a non-profit contract research organization. The contract is for the...

This federal contract was awarded by the Food and Drug Administration (FDA) to Battelle Memorial Institute, a nonprofit research and development organization, to study the effect of pH on the pharmacokinetics of nicotine in smokeless tobacco products. It is a delivery order issued against a larger IDIQ contract vehicle titled "Tobacco Products Pharmacology Study." The total ceiling value of this award is $1,690,972.00. The contract does not have a set-aside designation. The work...

This is a firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for $679,680.00. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. Under this task order, LBERI will conduct an assessment of tobacco products and tobacco product constituents' genetic toxicology using in vitro assays to compare the...

Battelle Memorial Institute received a $2.02M firm fixed price delivery order from the Food and Drug Administration to conduct research examining whether machine-generated nicotine yield can predict human nicotine exposure from electronic nicotine delivery systems (ENDS). The work is being performed in Calverton, Maryland, with an ultimate completion date of September 29, 2025. This award, made without any set-aside designation, represents a competitive procurement and falls under FDA's...

This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit organization, for a project titled "CYTOTOXICITY OF COMMON SOLVENTS USED IN LIQUID NICOTINE FORMULATIONS". The contract has a potential value of $1,149,919.00 and a completion date of April 15, 2021. This delivery order is part of a larger indefinite delivery/indefinite quantity...